Compare VCEL & SKWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCEL | SKWD |
|---|---|---|
| Founded | 1989 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 1997 | 2023 |
| Metric | VCEL | SKWD |
|---|---|---|
| Price | $36.47 | $48.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 12 |
| Target Price | $60.40 | ★ $65.30 |
| AVG Volume (30 Days) | ★ 592.9K | 368.2K |
| Earning Date | 11-06-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 236.54 | 3.25 |
| EPS | 0.25 | ★ 3.37 |
| Revenue | $258,716,999.00 | ★ $1,335,358,000.00 |
| Revenue This Year | $17.86 | $24.41 |
| Revenue Next Year | $18.55 | $30.82 |
| P/E Ratio | $148.09 | ★ $14.73 |
| Revenue Growth | 14.05 | ★ 22.27 |
| 52 Week Low | $29.24 | $41.28 |
| 52 Week High | $63.00 | $65.05 |
| Indicator | VCEL | SKWD |
|---|---|---|
| Relative Strength Index (RSI) | 44.40 | 56.20 |
| Support Level | $35.85 | $46.30 |
| Resistance Level | $42.68 | $50.19 |
| Average True Range (ATR) | 1.54 | 1.52 |
| MACD | -0.34 | 0.22 |
| Stochastic Oscillator | 9.01 | 78.35 |
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.